← Back
Data updated: Mar 10, 2026
KREITCHMAN PET CTR
Pharmaceuticals
KREITCHMAN PET CTR is a generic drug manufacturer with 3 FDA-approved products.
2013
Since
3
Drugs
-
Trials
2
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (3)
Discontinued (0)
Company Info
- First Approval
- 2013-12-09
- Latest
- 2016-05-19
- Applications
- 3